- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
464
0 new
Companies with a Value score of at least 3, ordered by Value score
464 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AMPH | US$44.09 | -3.1% | -21.3% | US$2.1b | US$59.00 | PE13.4x | E13.6% | n/a | ||
HALO | US$45.76 | -21.9% | 14.1% | US$5.7b | US$62.44 | PE14.8x | E21.1% | n/a | ||
KNSA | US$21.21 | -6.2% | 34.3% | US$1.5b | US$36.00 | PS4x | E58.9% | n/a | ||
EXAS | US$52.70 | 3.9% | -19.4% | US$10.0b | US$70.14 | PS3.6x | E72.6% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
IQV | US$194.38 | -8.1% | -7.2% | US$34.7b | US$254.40 | PE25.1x | E13.8% | 0% | ||
COLL | US$30.00 | -0.6% | 15.5% | US$959.4m | US$42.25 | PE10.9x | E22.0% | n/a | ||
ANIP | US$55.10 | -7.9% | 6.6% | US$1.1b | US$78.40 | PS1.9x | E57.0% | n/a | ||
TEVA | US$17.03 | 0.5% | 80.0% | US$19.0b | US$22.36 | PS1.2x | E65.8% | 0% | ||
MIRM | US$43.69 | -0.5% | 36.5% | US$2.0b | US$62.55 | PS6.8x | E71.5% | n/a | ||
ICLR | US$203.67 | -0.1% | -25.1% | US$16.1b | US$280.56 | PE22.5x | E13.6% | n/a | ||
MLAB | US$98.59 | -8.5% | 12.2% | US$541.8m | US$140.00 | PS2.3x | E124.8% | 0.6% | ||
FENC | US$4.64 | 3.6% | -47.5% | US$117.3m | US$13.60 | PS2.6x | E63.7% | n/a | ||
FOLD | US$9.59 | -7.5% | -9.9% | US$2.8b | US$17.75 | PS5.8x | E66.6% | n/a | ||
IVBX.F | US$5.09 | 11.0% | -7.5% | US$63.6b | US$7.13 | PS7.9x | E58.7% | n/a | ||
ACB | US$4.24 | -6.6% | -8.6% | US$319.7m | US$6.56 | PS1.1x | E154.3% | n/a | ||
PRGO | US$27.15 | 1.3% | -10.8% | US$3.7b | US$35.80 | PS0.8x | E63.8% | 4.1% | ||
AMRX | US$8.41 | -6.9% | 89.0% | US$2.6b | US$10.50 | PS1x | E153.9% | 0% | ||
FTRE | US$19.15 | -10.0% | -41.7% | US$1.7b | US$24.58 | PS0.6x | E68.1% | n/a | ||
GRRM.F | US$90.30 | 0% | -0.8% | US$2.4b | US$146.18 | PE21.4x | E21.7% | 1.8% | ||
EVO | US$5.30 | 16.5% | -48.7% | US$1.8b | US$5.91 | PS2.3x | E74.3% | n/a | ||
TCNN.F | US$6.31 | -10.0% | 9.7% | US$1.6b | US$16.81 | PS1x | E59.8% | n/a | ||
RCEL | US$13.05 | 1.4% | 24.3% | US$339.9m | US$16.92 | PS5.7x | E77.5% | n/a | ||
MKGA.F | US$142.05 | -9.1% | -18.8% | US$60.0b | US$190.16 | PE22.3x | E10.7% | 1.6% |